Short Interest in Fresenius Medical Care AG (NYSE:FMS) Drops By 24.5%

Fresenius Medical Care AG (NYSE:FMS - Get Free Report) was the recipient of a large drop in short interest during the month of February. As of February 15th, there was short interest totalling 607,700 shares, a drop of 24.5% from the January 31st total of 804,400 shares. Based on an average daily trading volume, of 253,200 shares, the short-interest ratio is currently 2.4 days.

Fresenius Medical Care Stock Performance

Fresenius Medical Care stock traded up $0.42 during trading on Friday, reaching $23.98. The company had a trading volume of 217,707 shares, compared to its average volume of 269,314. The firm has a market capitalization of $14.07 billion, a price-to-earnings ratio of 19.82, a price-to-earnings-growth ratio of 0.76 and a beta of 0.93. The company has a current ratio of 1.37, a quick ratio of 1.02 and a debt-to-equity ratio of 0.42. The firm's 50-day simple moving average is $23.51 and its 200 day simple moving average is $21.97. Fresenius Medical Care has a 52 week low of $17.93 and a 52 week high of $25.25.

Wall Street Analyst Weigh In

A number of analysts recently commented on the company. Truist Financial upped their price objective on Fresenius Medical Care from $23.00 to $25.00 and gave the company a "hold" rating in a research report on Monday, January 6th. Bank of America upgraded shares of Fresenius Medical Care from an "underperform" rating to a "neutral" rating in a research note on Monday, December 2nd. Finally, StockNews.com raised shares of Fresenius Medical Care from a "hold" rating to a "strong-buy" rating in a report on Wednesday, February 5th.

Remove Ads

Hedge Funds Weigh In On Fresenius Medical Care

A number of hedge funds have recently modified their holdings of the company. Callan Capital LLC bought a new stake in shares of Fresenius Medical Care during the 4th quarter valued at $297,000. Sanctuary Advisors LLC bought a new stake in Fresenius Medical Care during the fourth quarter valued at about $983,000. ABC Arbitrage SA bought a new stake in Fresenius Medical Care during the fourth quarter valued at about $4,215,000. Verition Fund Management LLC purchased a new position in shares of Fresenius Medical Care in the third quarter valued at about $237,000. Finally, JPMorgan Chase & Co. boosted its stake in shares of Fresenius Medical Care by 18.2% in the third quarter. JPMorgan Chase & Co. now owns 9,902 shares of the company's stock worth $211,000 after acquiring an additional 1,528 shares during the period. 8.37% of the stock is currently owned by institutional investors.

About Fresenius Medical Care

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.